| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/08/2000 | US6022886 Endothelin receptor antagonists |
| 02/08/2000 | US6022885 Pyrrolidine and thiazole derivatives with antibacterial and . metallo-.beta-lactamase inhibitory properties |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022883 Heterocyclyloxybenzoylguanidines |
| 02/08/2000 | US6022880 Substituted pyridylamino indoles |
| 02/08/2000 | US6022879 Bathocuproine treatment of neurologic disease |
| 02/08/2000 | US6022878 Inhibitors of rotamase enzyme activity |
| 02/08/2000 | US6022877 Use of (+)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl)ethyl]-4-piperidin emethanol in treating depressive disorders and bipolar disorders |
| 02/08/2000 | US6022876 L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
| 02/08/2000 | US6022875 Use of substituted 2,4-imidazolidinedione compounds as analgesics |
| 02/08/2000 | US6022873 Metalloproteinase inhibitors |
| 02/08/2000 | US6022868 Substituted azacyclic or azabicyclic compounds |
| 02/08/2000 | US6022867 Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals |
| 02/08/2000 | US6022866 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 02/08/2000 | US6022862 Use of pseudopterosins for promoting wound healing |
| 02/08/2000 | US6022855 Novel variants of the naturally-occurring protease inhibitor, alpha1-antitrypsin and derived peptides comprising a sequence of-arg-xaa-xaa-arg-; viricides; bactericides; blocking of endoproteolytic activation of a bacterial toxin |
| 02/08/2000 | US6022851 Cyclic polypeptides for treatment and prophylaxis of antibiotic-resistant bacterial infectious diseases by administration with an excipient |
| 02/08/2000 | US6022850 Use of hemoglobin in the treatment of stroke |
| 02/08/2000 | US6022565 Extract of jewelweed (impatiens species such as impatiens capensis, impatiens biflora, impatiens balsamea, and impatiens pallida), extract of plantain leaf, and aqueous colloidal dispersion of subdivided whole oat grains; poison ivy |
| 02/08/2000 | US6022564 Method for producing a microparticle |
| 02/08/2000 | US6022563 Phenylbutazone carrier formulation |
| 02/08/2000 | US6022558 Transdermal preparations of oxicams |
| 02/08/2000 | US6022556 Swellable wound dressing materials |
| 02/08/2000 | US6022555 Animal feed containing carboxylic acids |
| 02/08/2000 | US6022551 Rapidly disinfects surfaces including the hands; comprising alcohol, specific antimicrobial(s) such as benzethonium chloride, and cocophosphatidyl-dimonium chloride, and a copolymer carbomer thickener |
| 02/08/2000 | US6022545 Usage of pathogen-killing foams |
| 02/08/2000 | US6022542 Polypeptide which serves as reagent in diagnostic kit for detecting an anti-herpesvirus antibody present in a biological sample; kaposi's sarcoma (ks) and retroperitoneal fibromatosis (rf) |
| 02/08/2000 | US6022538 Administering adriamycin or cisplatin, and cell therapy cells modified by in vitro treatment with a cytokine and gamma irradiation at a dose to irreversibly arrest cell proliferation but not interfere with the cytotoxic activity |
| 02/08/2000 | US6022533 Tablets containing anion exchange resin |
| 02/08/2000 | US6022527 Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof |
| 02/08/2000 | US6022379 Hair dye |
| 02/08/2000 | CA2234364C Compositions for inhibiting platelet aggregation |
| 02/08/2000 | CA2150016C Pyrrolopyrimidines as crf antagonists |
| 02/08/2000 | CA2127677C 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3.3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof |
| 02/08/2000 | CA2090942C Anti-tumour compounds containing quinazoline and tetrazole rings |
| 02/08/2000 | CA2014467C 3-substituted-2-oxindole derivatives |
| 02/08/2000 | CA2014379C Compounds |
| 02/08/2000 | CA2006387C Xanthine derivatives with adenosine-antagonistic activity |
| 02/08/2000 | CA2004597C Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo-[4,5-c]quinoline-4-amine |
| 02/08/2000 | CA2004064C Supported drugs with increased dissolution rate, and a process for theirpreparation |
| 02/08/2000 | CA1340892C Bisplatinum complexes as chemotherapeutic agents |
| 02/07/2000 | CA2279732A1 Method of inhibition of human glycogen phosphorylase |
| 02/06/2000 | CA2279747A1 Estrogen agonists/antagonists |
| 02/03/2000 | WO2000005395A1 Method for obtaining fatty acids from biomass by combined in-situ extraction, reaction and chromatography using compressed gases |
| 02/03/2000 | WO2000005394A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates |
| 02/03/2000 | WO2000005393A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005359A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | WO2000005358A1 Methods for purifying nucleic acids |
| 02/03/2000 | WO2000005348A1 Pneumococcal nrdg protein |
| 02/03/2000 | WO2000005269A1 Polymer complexes of glucuronoglucanes |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005239A1 Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines |
| 02/03/2000 | WO2000005232A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/03/2000 | WO2000005231A1 Fkbp inhibitors |
| 02/03/2000 | WO2000005229A1 Phenylindole derivatives as 5-ht2a receptor ligands |
| 02/03/2000 | WO2000005225A1 Biphenyl derivatives |
| 02/03/2000 | WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor |
| 02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 02/03/2000 | WO2000005219A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/03/2000 | WO2000005218A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 02/03/2000 | WO2000005217A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000005210A1 N,n-substituted cyclic amine derivatives |
| 02/03/2000 | WO2000005207A1 Substituted phenylamidines with antithrombotic action |
| 02/03/2000 | WO2000005206A1 Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
| 02/03/2000 | WO2000005201A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 02/03/2000 | WO2000005196A1 α-AMINO ACID PHENYL ESTER DERIVATIVES |
| 02/03/2000 | WO2000004954A2 Novel urokinase inhibitors |
| 02/03/2000 | WO2000004939A1 Dental pin |
| 02/03/2000 | WO2000004937A1 Flat flexible materials |
| 02/03/2000 | WO2000004926A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 02/03/2000 | WO2000004925A1 Slow release formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004924A1 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004912A1 Therapeutic agent for dementia, comprising ginseng extract |
| 02/03/2000 | WO2000004911A1 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
| 02/03/2000 | WO2000004908A1 Composite biocidal particles |
| 02/03/2000 | WO2000004907A1 An antilipemic formulation |
| 02/03/2000 | WO2000004905A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof |
| 02/03/2000 | WO2000004904A1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
| 02/03/2000 | WO2000004903A1 The use of cd4-binding small molecules to inhibit hiv infection |
| 02/03/2000 | WO2000004902A1 Stabilized carvedilol injection solution |
| 02/03/2000 | WO2000004901A1 Small molecule inhibitors of bcl-2 proteins |
| 02/03/2000 | WO2000004900A1 Substituted benzimidazole antiviral agents |
| 02/03/2000 | WO2000004899A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | WO2000004898A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | WO2000004897A1 Bioimplant formulation |
| 02/03/2000 | WO2000004896A1 Solid preparation containing sparingly soluble nsaids |
| 02/03/2000 | WO2000004895A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 02/03/2000 | WO2000004894A2 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 02/03/2000 | WO2000004893A2 Imidazoline receptor binding compounds |
| 02/03/2000 | WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/03/2000 | WO2000004891A2 Anti-ulcer composition |
| 02/03/2000 | WO2000004890A1 Use of glucose uptake enhancer for reducing apoptosis |
| 02/03/2000 | WO2000004889A1 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 02/03/2000 | WO2000004888A2 Use of cyclodextrins for the treatment of cerebral ischaemia and central nervous system injury |